Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Antimicrob Agents Chemother
2015 Nov 09;601:495-506. doi: 10.1128/AAC.01998-15.
Show Gene links
Show Anatomy links
Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli.
???displayArticle.abstract???
CA-MA is a hybrid antimicrobial peptide (AMP) derived from two naturally occurring AMPs, cecropin A and magainin 2. CA-MA shows strong antimicrobial activity against Gram-negative and Gram-positive bacteria but also exhibits cytotoxicity toward mammalian cells. Our objective was to identify CA-MA analogues with reduced cytotoxicity by systematic replacement of amino acids with positively charged R groups (His and Lys), aliphatic R groups (Leu), or polar R groups (Glu). Among the CA-MA analogues studied (CMA1 to -6), CMA3 showed the strongest antimicrobial activity, including against drug-resistant Escherichia coli and Pseudomonas aeruginosa strains isolated from hospital patients. CMA3 appeared to act by inducing pore formation (toroidal model) in the bacterial membrane. In cytotoxicity assays, CMA3 showed little cytotoxicity toward human red blood cells (hRBCs) or HaCaT cells. Additionally, no fluorescence was released from small or giant unilamellar vesicles exposed to 60 μM CMA3 for 80 s, whereas fluorescence was released within 35 s upon exposure to CA-MA. CMA3 also exerted strong lipopolysaccharide (LPS)-neutralizing activity in RAW 264.7 cells, and BALB/c mice exposed to LPS after infection by Escherichia coli showed improved survival after administration of one 0.5-mg/kg of body weight or 1-mg/kg dose of CMA3. Finally, in a mouse model of septic shock, CMA3 reduced the levels of proinflammatory factors, including both nitric oxide and white blood cells, and correspondingly reduced lungtissue damage. This study suggests that CMA3 is an antimicrobial/antiendotoxin peptide that could serve as the basis for the development of anti-inflammatory and/or antimicrobial agents with low cytotoxicity.
Bahar,
Antimicrobial peptides.
2013,
Pubmed
Belkaid,
Effector and memory T cell responses to commensal bacteria.
2013,
Pubmed
Bhattacharjya,
De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs.
2010,
Pubmed
Brogden,
Oral inflammation, a role for antimicrobial peptide modulation of cytokine and chemokine responses.
2013,
Pubmed
Clark,
Old meets new: the interaction between innate and adaptive immunity.
2005,
Pubmed
Cruz,
Antimicrobial peptides: promising compounds against pathogenic microorganisms.
2014,
Pubmed
De Smet,
Human antimicrobial peptides: defensins, cathelicidins and histatins.
2005,
Pubmed
Duplantier,
The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds.
2013,
Pubmed
Estes,
Electroformation of giant liposomes from spin-coated films of lipids.
2005,
Pubmed
Frew,
Antimicrobial peptides and pregnancy.
2011,
Pubmed
Gaspar,
From antimicrobial to anticancer peptides. A review.
2013,
Pubmed
Habermann,
[Sequence analysis of melittin from tryptic and peptic degradation products].
1967,
Pubmed
Haney,
Peptide design for antimicrobial and immunomodulatory applications.
2013,
Pubmed
Hartmann,
Damage of the bacterial cell envelope by antimicrobial peptides gramicidin S and PGLa as revealed by transmission and scanning electron microscopy.
2010,
Pubmed
Heinbockel,
Preclinical investigations reveal the broad-spectrum neutralizing activity of peptide Pep19-2.5 on bacterial pathogenicity factors.
2013,
Pubmed
Henzler Wildman,
Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37.
2003,
Pubmed
Hotchkiss,
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.
2013,
Pubmed
Jacob,
Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.
2013,
Pubmed
Kim,
C-terminal amidation of PMAP-23: translocation to the inner membrane of Gram-negative bacteria.
2011,
Pubmed
Lai,
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.
2009,
Pubmed
Lee,
A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice.
2014,
Pubmed
Lee,
Antimicrobial HPA3NT3 peptide analogs: placement of aromatic rings and positive charges are key determinants for cell selectivity and mechanism of action.
2013,
Pubmed
Lee,
Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1.
2002,
Pubmed
Lei,
siRNA targeting mCD14 inhibits TNF-α, MIP-2, and IL-6 secretion and NO production from LPS-induced RAW264.7 cells.
2011,
Pubmed
Liu,
Chebulagic acid inhibits the LPS-induced expression of TNF-α and IL-1β in endothelial cells by suppressing MAPK activation.
2015,
Pubmed
López-Abarrategui,
LPS inmobilization on porous and non-porous supports as an approach for the isolation of anti-LPS host-defense peptides.
2013,
Pubmed
Majchrzykiewicz,
Generic and specific adaptive responses of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides, bacitracin, LL-37, and nisin.
2010,
Pubmed
Mandal,
Recombinant probiotics with antimicrobial peptides: a dual strategy to improve immune response in immunocompromised patients.
2014,
Pubmed
Mayer,
Vesicles of variable sizes produced by a rapid extrusion procedure.
1986,
Pubmed
Melo,
Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations.
2009,
Pubmed
Mereuta,
Slowing down single-molecule trafficking through a protein nanopore reveals intermediates for peptide translocation.
2014,
Pubmed
Miller,
Immunity against Staphylococcus aureus cutaneous infections.
2011,
Pubmed
Nell,
Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application.
2006,
Pubmed
Oh,
Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.
2000,
Pubmed
,
Xenbase
Papareddy,
C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules.
2010,
Pubmed
Park,
A plausible mode of action of pseudin-2, an antimicrobial peptide from Pseudis paradoxa.
2011,
Pubmed
Park,
Synthetic diastereomeric-antimicrobial peptide: antibacterial activity against multiple drug resistant clinical isolates.
2011,
Pubmed
Ray,
Bacterial cell wall macroamphiphiles: pathogen-/microbe-associated molecular patterns detected by mammalian innate immune system.
2013,
Pubmed
Rosenfeld,
Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides.
2010,
Pubmed
Shin,
Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells.
2000,
Pubmed
Shin,
Cecropin A - magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect.
1998,
Pubmed
,
Xenbase
Steiner,
Secondary structure of the cecropins: antibacterial peptides from the moth Hyalophora cecropia.
1982,
Pubmed
Stewart,
Colorimetric determination of phospholipids with ammonium ferrothiocyanate.
1980,
Pubmed
Takada,
Endoplasmic reticulum stress mediates nitric oxide-induced chondrocyte apoptosis.
2013,
Pubmed
Takagi,
A bovine myeloid antimicrobial peptide (BMAP-28) kills methicillin-resistant Staphylococcus aureus but promotes adherence of the bacteria.
2014,
Pubmed
To,
Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells.
2013,
Pubmed
Wu,
Bupleurum polysaccharides attenuates lipopolysaccharide-induced inflammation via modulating Toll-like receptor 4 signaling.
2013,
Pubmed
Xiao,
Emodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-κB in mice.
2014,
Pubmed
Xie,
Defensins and sepsis.
2014,
Pubmed
Zasloff,
Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.
1987,
Pubmed
,
Xenbase
Zhang,
Resveratrol exerts an anti-apoptotic effect on human bronchial epithelial cells undergoing cigarette smoke exposure.
2015,
Pubmed
